World Health Organization recommends GLP-1s amid obesity crisis
Mrinalika Roy | ReutersTrump announces lower prices coming for GLP-1 drugs Zepbound, WegovyPresident Donald Trump announces discounted pricing for Zepbound...
Mrinalika Roy | ReutersTrump announces lower prices coming for GLP-1 drugs Zepbound, WegovyPresident Donald Trump announces discounted pricing for Zepbound...
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO)...
What we do Poor nutrition and inadequate physical activity are significant risk factors for obesity and other chronic diseases, such...
Patients with obesity who adopt a low-calorie diet need to know the risks that come with it, particularly the chances...
A new study shows people in countries with different obesity rates burn about the same number of calories. PCH-Vector/iStockphoto via...
Key factsIn 2022, 1 in 8 people in the world were living with obesity. Worldwide adult obesity has more than...
In a few short years, excitement about groundbreaking anti-obesity drugs made Novo Nordisk Europe’s most highly valued company and Eli...
On October 24, the House of Lords published a damning report on the nation’s food and UPF (ultra-processed food). The...
Jaye Rochon struggled to lose weight for years. But she felt as if a burden had lifted when she discovered...